Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Lmo2
REST API REST API
Mus musculus
Lmo2 is differentially expressed in 228 experiments: 105 organism parts: liver, testis, ... (103 more);, 18 disease states: normal, EL-4 tumor-bearing, ... (16 more);, 49 cell types 9 cell lines 32 compound treatments and 33 other conditions.
Synonyms 'Rbtn2', 'Rhom-2', 'Rbtn-2'
Orthologs Lmo2 (Rattus norvegicus)   RBTN2_BOVIN (Bos taurus)   Q71LH8_CHICK (Gallus gallus)   LMO2 (Homo sapiens)   Bx (Drosophila melanogaster)   lmo2 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term DNA binding, protein binding, protein complex, metal ion binding, positive regulation of transcription from RNA polymerase II promoter, nucleus, chromatin binding, zinc ion binding, negative regulation of erythrocyte differentiation
InterPro Term Znf_LIM
Search EB-eye ENSMUSG00000032698
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-1479, E-GEOD-20160, E-GEOD-3963, E-GEOD-2866, ... (55 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-MEXP-1689, E-GEOD-10246, E-MEXP-2554, E-GEOD-11259

Factor Value U/D Experiments
R10
1
E-MEXP-1689
RAW264.7
1
E-GEOD-10246
67NR
1
E-GEOD-11259
4T1
1
E-GEOD-11259
I-11
1
1
E-MEXP-1689
1
E-GEOD-10246
3 more value(s).


Cell type

studied in E-GEOD-2585, E-GEOD-7069, E-GEOD-7764, E-GEOD-829, E-GEOD-4142, ... (25 experiments)

Factor Value U/D Experiments
hematopoietic stem cell
3
E-GEOD-7069, E-MEXP-1158, E-GEOD-20377
primordial germ cell
1
E-MEXP-1158
interstitial cell
1
E-GEOD-829
granule cell precursor
1
E-GEOD-2426
B220+ B cell
1
1
E-MTAB-25
germinal center B cell
1
E-GEOD-4142
43 more value(s).


Disease state

studied in E-MEXP-1296, E-GEOD-21927, E-GEOD-19004, E-GEOD-642, E-GEOD-21902, ... (12 experiments)

Factor Value U/D Experiments
normal
2
4
E-MEXP-1444, E-GEOD-2514, E-MEXP-1623, E-MEXP-1296, E-MEXP-1137, ... (6 experiments)
type 2 diabetes
1
E-GEOD-642
tumor
1
E-GEOD-21902
preneoplastic breast cancer
1
E-GEOD-2528
MMTV-Myc
1
E-GEOD-15904
lung adenocarcinoma
1
E-GEOD-2514
12 more value(s).


Compound treatment

studied in E-GEOD-21711, E-GEOD-2565, E-TABM-903, E-GEOD-1301, E-GEOD-5901, ... (24 experiments)

Factor Value U/D Experiments
control
1
4
E-GEOD-7694, E-GEOD-4671, E-GEOD-469, E-GEOD-3565, E-TABM-903 ... (5 experiments)
retinoic acid
2
E-GEOD-484, E-TABM-903
none
4
5
E-GEOD-5304, E-MEXP-703, E-MEXP-1702, E-MEXP-1814, E-GEOD-5901, ... (9 experiments)
cardiotoxin
1
2
E-GEOD-5304, E-MEXP-703, E-GEOD-469
R848
1
E-TABM-310
allergen
1
E-GEOD-483
26 more value(s).


Agent

studied in E-GEOD-26086

Factor Value U/D Experiments
not specified
1
1
E-GEOD-26086
CD71-24_4h_100nMDex_333uMDMOG
1
1
E-GEOD-26086


Amount to core
studied in E-GEOD-18858

Clinical treatment
studied in E-TABM-195, E-GEOD-2411

Cohort
studied in E-GEOD-20524

Developmental stage
studied in E-MEXP-1853, E-GEOD-4870, E-MEXP-955, E-GEOD-8191, E-GEOD-5306, ... (21 experiments)

Diet
studied in E-GEOD-16377

dose or concentration
studied in E-GEOD-18858

Family history
studied in E-GEOD-19194

Fraction
studied in E-TABM-363

Genetic modification
studied in E-GEOD-3172

Genotype
studied in E-GEOD-19684, E-GEOD-19004, E-GEOD-7020, E-MEXP-1649, E-TABM-285, ... (33 experiments)

Growth condition
studied in E-GEOD-339

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Individual
studied in E-GEOD-18858

Infection
studied in E-MEXP-1717, E-GEOD-20302, E-MEXP-1942, E-GEOD-3414

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Injury
studied in E-GEOD-1999

Irradiate
studied in E-GEOD-4066

Observation
studied in E-GEOD-3594

Organism
studied in E-MEXP-667

Protocol type
studied in E-MEXP-1358, E-GEOD-16192, E-GEOD-2917

Rna integrity number
studied in E-GEOD-18858

sample preservation
studied in E-GEOD-18858

Sex
studied in E-GEOD-3463, E-GEOD-75

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15902

Strain or line
studied in E-GEOD-3100, E-MTAB-76, E-TABM-285, E-GEOD-1623, E-GEOD-7762, ... (7 experiments)

Treatment
studied in E-MTAB-76, E-GEOD-21902, E-GEOD-18344, E-GEOD-22009, E-GEOD-21841, ... (8 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.198 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM